Cellular Origins Launches its Configurable Robotic Platform, Constellation
Cellular Origins has announced the launch of Constellation, its closed, configurable, robotic platform at the International Society for Cell and Gene Therapy Annual Meeting 2023.
GenNext® Technologies Announces Partnership with Emery Pharma
GenNext Technologies, Inc., a growth-stage company that provides structural biology instrumentation, software, and services, announced today that it is collaborating with Emery Pharma.
Echo® MS Center of Excellence Launches at SCIEX Headquarters
SCIEX, celebrates the opening of the Echo® MS Center of Excellence.
OncoHost To Present PROphet® Biomarker Model That Accurately Predicts Clinical Benefit to ICI-Based Treatment
OncoHost has announced that it will give a poster presentation demonstrating the accuracy of its PROphet® biomarker model at the upcoming American Society of Clinical Oncology Annual Meeting, taking place June 2-6, 2023, in Chicago, Illinois.
Productive, Error-Free 2D Tube Rack Reading
Ziath, an Azenta Life sciences company reports that the high-speed of reading and error-free decoding offered by their DataPaq™ Mirage 2D tube rack reader has made it the instrument of choice for many life science labs.
Beckman Coulter Unveils Next Generation Immunoassay Analyzer
Beckman Coulter has unveiled the DxI 9000 Access Immunoassay Analyzer, the most productive immunoassay analyzer per footprint.
Ansa Biotechnologies Announces First Shipments of Complex Clonal DNA Sequences to Customers in Its Early Access Program
Ansa Biotechnologies, Inc., announced that it has synthesized and delivered complex clonal DNA sequences to multiple customers participating in its Early Access Program.
bit.bio Launches New Custom Disease Model Cells Offering
bit.bio today launches its new Custom ioDisease Model CellsTM offering. This offering allows scientists to commission their disease-relevant mutation of interest in bit.bio's human induced pluripotent stem cell (iPSC)-derived cells powered by opti-ox technology.
Cell and Gene Therapy CDMO Targets North American Growth With Major US Acquisition
uBriGene, a cell & gene therapy contract development and manufacturing organization, is expanding into the US market with the acquisition of a state-of-the-art GMP manufacturing facility from NASDAQ-listed company Mustang Bio, Inc.
Thermo Fisher Scientific Announces FDA Clearance of Breakthrough Immunoassays To Aid in the Risk Assessment of Preeclampsia
First and only blood-based biomarkers for the risk assessment and clinical management of preeclampsia with severe features.